SurgePays (SURG) to Announce Earnings on Wednesday

SurgePays (NASDAQ:SURG) is expected to be announcing its Q2 2026 results before the market opens on Wednesday, August 12th. Analysts expect the company to announce earnings of ($0.11) per share and revenue of $13.80 million for the quarter. Investors can check the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Wednesday, August 12, 2026 at 5:00 PM ET.

SurgePays (NASDAQ:SURG) last released its quarterly earnings results on Wednesday, May 20th. The medical equipment provider reported ($0.51) EPS for the quarter, missing the consensus estimate of ($0.19) by ($0.32). The company had revenue of $15.98 million for the quarter, compared to analyst estimates of $15.49 million. On average, analysts expect SurgePays to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

SurgePays Stock Performance

NASDAQ:SURG opened at $0.21 on Wednesday. SurgePays has a 52 week low of $0.20 and a 52 week high of $3.22. The firm’s 50-day simple moving average is $0.39 and its 200 day simple moving average is $0.68. The firm has a market cap of $5.28 million, a price-to-earnings ratio of -0.11 and a beta of 0.42.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on SURG shares. Weiss Ratings restated a “sell (e+)” rating on shares of SurgePays in a research report on Friday, May 22nd. Ascendiant Capital Markets cut their price target on SurgePays from $5.00 to $3.50 and set a “buy” rating for the company in a research note on Wednesday, June 10th. Finally, Zacks Research downgraded SurgePays from a “hold” rating to a “strong sell” rating in a research report on Friday, May 15th. One investment analyst has rated the stock with a Buy rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, SurgePays presently has a consensus rating of “Reduce” and a consensus target price of $3.50.

Institutional Investors Weigh In On SurgePays

A number of large investors have recently bought and sold shares of SURG. Jane Street Group LLC bought a new stake in shares of SurgePays during the 2nd quarter worth approximately $42,000. Goldman Sachs Group Inc. acquired a new position in SurgePays during the first quarter valued at approximately $28,000. NewEdge Advisors LLC boosted its holdings in shares of SurgePays by 46.2% in the 2nd quarter. NewEdge Advisors LLC now owns 19,000 shares of the medical equipment provider’s stock valued at $59,000 after purchasing an additional 6,000 shares in the last quarter. Squarepoint Ops LLC acquired a new position in SurgePays during the fourth quarter worth about $52,000. Finally, XTX Topco Ltd bought a new position in shares of SurgePays in the second quarter worth about $125,000. 6.94% of the stock is currently owned by institutional investors and hedge funds.

About SurgePays

SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.